Acute cholinergic syndrome in a patient with Alzheimer's disease taking the prescribed dose of galantamine
Sign Up to like & getrecommendations! Published in 2018 at "Psychogeriatrics"
DOI: 10.1111/psyg.12341
Abstract: Decreased levels of acetylcholine contribute to cognitive dysfunction in Alzheimer’s disease (AD). Acetylcholinesterase (AChE) inhibitors prevent the degradation of acetylcholine by inhibiting the enzyme AChE, resulting in increased levels of acetylcholine in the synaptic endings.… read more here.
Keywords: galantamine; day; cholinergic syndrome; acute cholinergic ... See more keywords